AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
Public ClinicalTrials.gov record NCT02141672. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To assess the efficacy of 2 doses of voclosporin compared to placebo in achieving complete remission after 24 weeks of therapy in subjects with active lupus nephritis.
Study identification
- NCT ID
- NCT02141672
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 265 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2014 (Type not available)
- Primary completion
- Jul 2016 (Actual)
- Completion
- Jan 2017 (Actual)
- Last update posted
- May 18, 2021
2014 – 2017
United States locations
- U.S. sites
- 14
- U.S. states
- 9
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AURA-LV Site | Los Angeles | California | 90095 | — |
| AURA-LV Site | Palo Alto | California | 94305 | — |
| AURA-LV Site | Gainesville | Florida | 32610 | — |
| AURA-LV Site | Miami | Florida | 33165 | — |
| AURA-LV Site | Farmington Hills | Michigan | 48334 | — |
| AURA-LV Site | Brooklyn | New York | 11203 | — |
| AURA-LV Site | New York | New York | 10016 | — |
| AURA-LV Site | Chapel Hill | North Carolina | 27599 | — |
| AURA-LV Site | Charlotte | North Carolina | 28204 | — |
| AURA-LV Site | Columbus | Ohio | 43210 | — |
| AURA-LV Site | Hershey | Pennsylvania | 17033 | — |
| AURA-LV Site | Chattanooga | Tennessee | 37408 | — |
| AURA-LV Site | Dallas | Texas | 75390 | — |
| AURA-LV Site | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 72 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02141672, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 18, 2021 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02141672 live on ClinicalTrials.gov.